AstraZenecas Stock Drops on Wainuas Setback in ATTR-CM Study
AZN shares tumble after Wainua missed the primary endpoint in a late-stage ATTR-CM study, raising questions about its expansion into…
92,830$
0,26%
Echtzeit-Aktienkurs Astrazeneca PLC (Spons. ADRs)
Bid:
Ask:
Nachrichten zur Astrazeneca PLC (Spons. ADRs) Aktie
Opening Bell: Wall Street startet im Plus; AstraZeneca, PepsiCo, Fuelcell Energy, Arista Networks. ...
Trotz zunehmender militärischer Auseinandersetzungen zwischen den USA und dem Iran werden die US-Aktienmärkte am Donnerstag moderat im Plus erwartet. Eine…
AstraZeneca stock drops 9% after heart drug trial miss deals rare blow to pharma powerhouse
A late-stage clinical trial failed to miss its primary endpoint, U.K.s laregst drugmaker said Thursday.…
Stocks making the biggest moves premarket: AstraZeneca, PepsiCo, Salesforce, Levi & more
These are the stocks posting the largest moves in the premarket.…
FTSE 100 dragged lower by AstraZeneca
The FTSE 100 fell on Thursday as AstraZeneca dragged the index lower after releasing disappointing trial results for a cardiovascular drug.…
AstraZeneca sees stock market value slump by more than £20bn after drug setback
The FTSE 100 firm found the Wainua drug failed to meet a goal to reduce deaths related to heart disease.…
AstraZenecas £19bn blow as Wainua heart drug fails key late-stage trial
AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) shares fell 9.55% in early trading, wiping £19 billion from the companys valuation, after its Wainua drug…
AstraZenecas £19bn blow as Wainua heart drug fails key late-stage trial
AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) shares fell 9.55% in early trading, wiping £19 billion from the companys valuation, after its Wainua drug…
FTSE 100 Live: London index hit by AstraZeneca failure, Computacenter and Playtech soar
FTSE 100 down 61 points to AstraZeneca tumbles after clinical trial failure Computacenter and Playtech soar after trading updates 10.26am: Playtech…
FTSE 100 Live: London index stands alone in red after AstraZeneca trial failure
9.31am: European markets rebound, apart from the FTSE After an hour and a half of trading, European markets are broadly higher,…
FTSE 100 Live: Index opens lower after AstraZeneca trial failure, Computacenter surges
8.14am: AstraZeneca drags FTSE into red The FTSE 100 opened higher in the first two minutes of trading but has…
FTSE 100 Live: AstraZeneca drags while Computacenter soars, US AI stocks gain
FTSE 100 down 39 points to 10,450 AstraZeneca tumbles after clinical trial failure Computacenter and Playtech soar after trading updates 2.42pm:…
FTSE 100 Live: AstraZeneca exerts big drag, Computacenter and Playtech soar
FTSE 100 down 49 points to 10,440 AstraZeneca tumbles after clinical trial failure Computacenter and Playtech soar after trading updates 2.29pm:…
AstraZeneca Aktie: Kaufchance - trotz gesenktem Kursziel!
London (www.aktiencheck.de) - AstraZeneca-Aktienanalyse von HSBC:Die HSBC habe das Kursziel für die Aktie von AstraZeneca plc (ISIN: GB0009895292, WKN: 886455,…
Pfizer or AstraZeneca: Which Stock Offers Better Long-Term Potential?
AZN targets continued 2026 growth with expanding blockbuster medicines, a strong pipeline and 2030 revenue goals as it outpaces Pfizer…
AstraZeneca PLC (AZN) Discusses Progress in Sustainability Strategy and the Role of AI in Healthcare Innovation Transcript
…
Citi keeps AstraZeneca on buy ahead of second-quarter results
AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) has been kept on a buy rating by Citi, which pointed to a run of late-stage drug…
AstraZenecas Enhertu Wins EU Nod for HER2-Positive Solid Tumors
AZNs Enhertu wins its sixth EU indication with a tumor-agnostic approval. Datroway moves closer to a first-line TNBC EU nod…
Jefferies names AstraZeneca a top pick ahead of pivotal heart drug readout
Jefferies has reiterated its buy rating on AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) and named the drugmaker a Franchise Pick, framing an approaching...…
Astrazeneca (AZN) Ascends While Market Falls: Some Facts to Note
In the most recent trading session, Astrazeneca (AZN) closed at $185.68, indicating a +1.45% shift from the previous trading day.…
The Zacks Analyst Blog Highlights Applied Materials, GE, AstraZeneca, Team and Applied Energetics
Applied Materials, GE Aerospace and AstraZeneca headline Zacks research picks, backed by strong industry outperformance and key growth drivers.…
AstraZeneca Stock Down 7% in 3 Months: Should You Buy, Sell or Hold?
AZN shares fell after a camizestrant setback, but blockbuster drugs, oncology growth and a deep pipeline support long-term targets.…
Top Stock Reports for Applied Materials, GE & AstraZeneca
Todays Research Daily features new research reports on 16 major stocks, including Applied Materials, Inc. (AMAT), GE Aerospace (GE) and…
AstraZeneca says AI is raising its odds where most drugs fail
The most expensive product in modern business is the one that never ships. Nowhere is that more true than in…
Astrazeneca (AZN) Outperforms Broader Market: What You Need to Know
In the most recent trading session, Astrazeneca (AZN) closed at $182.28, indicating a +1.86% shift from the previous trading day.…
Project Nashville: GSK boosts oncology rebuild with $11 billion Nuvalent deal
GSKs record $10.6 billion deal for U.S. company Nuvalent will accelerate the British drugmakers rebuild of its cancer drug business…
JNJ and AZN Face Patent Headwinds: Which Stock Looks Stronger Now?
J&Js diversified healthcare business and growth outlook help it stand out against AstraZeneca despite patent and legal challenges.…
AstraZeneca CEO says AI is reshaping drug development — and helping boost the odds of success
AstraZeneca CEO Pascal Soriot said AI is helping the company develop medicines faster and make smarter decisions throughout the research…
AstraZeneca Broadens US Growth Push
AstraZeneca CFO Aradhana Sarin discusses how the pharmaceutical company is broadening its US shareholder base and plans to generate $80…
AstraZeneca CEO: AI is affecting every part of our company
AstraZeneca CEO Pascal Soriot joins CNBC’s Angelica Peebles to discuss the most promising drugs in AstraZeneca’s pipeline. He says the…
Can AstraZenecas Expanding Cancer Portfolio Sustain Momentum?
AstraZenecas oncology sales hit $6.8B in first-quarter 2026, fueled by key cancer drugs. New launches and late-stage pipeline assets support…
Leading Bank maintains sell on AstraZeneca at 11,500p as ASCO glow fails to resolve key pipeline questions
Deutsche Bank has kept its sell rating and 11,500p price target on AstraZeneca PLC (LSE:AZN, NASDAQ:AZN), the FTSE 100 pharmaceuticals…
ASCO 2026: A quiet conference for European pharma, but AstraZeneca and Roche both have work to do
This years American Society of Clinical Oncology (ASCO) conference has been a subdued affair for European pharmaceutical companies, with no…
Admission of Further Securities to Trading
1 June 2026Notification of Admission of Further Securities to Trading (PRM 1.6.4R)The following notification is made in accordance with The…
US bank sees positive risk-reward for AstraZeneca ahead of pivotal heart drug trial
Citi sees the risk-reward balance as favourable for AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) ahead of headline results from a pivotal trial of…
US bank sees positive risk-reward for AstraZeneca ahead of pivotal heart drug trial
Citi sees the risk-reward balance as favourable for AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) ahead of headline results from a pivotal trial of…
AIM movers: Potential farm out partners for Borders & Southern and CelLBxHealth deal with AstraZeneca
Parsortix liquid biopsy system developer CelLBxHealth (LON: CLBX) has entered an agreement with AstraZeneca which makes the AIM company a…
CelLBxHealth shares soar after inking agreement with AstraZeneca
AIM-listed CelLBxHealth has secured a Master Services Agreement with AstraZeneca, giving the circulating tumour cell specialist qualified service provider status…
AstraZeneca: 8% Q1 Revenue Growth And Imfinzi/Ultomiris Trial Data Wins
…
AZN, Daiichis Enhertu Gets FDA Nod for Two New Breast Cancer Settings
AstraZeneca and Daiichi win FDA approval for Enhertu in two new HER2-positive early breast cancer treatment settings.…
AstraZeneca Gets FDA Nod for New Hypertension Drug Baxfendy
AZNs Baxfendy wins FDA nod as the first aldosterone synthase inhibitor for adults with uncontrolled hypertension.…
AstraZeneca wins US approval for first-in-class blood pressure drug and expands cancer treatment Enhertu
AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) has secured US approval for Baxfendy, the first in a new class of blood pressure medication…
AstraZeneca wins US approval for first-in-class blood pressure drug and expands cancer treatment Enhertu
AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) has secured US approval for Baxfendy, the first in a new class of blood pressure medication…
AstraZeneca wins US FDA approval for hypertension drug Baxfendy
…
Top Stock Reports for Costco, Coca-Cola & AstraZeneca
Costco, Coca-Cola and AstraZeneca lead Zacks top stock reports as strong earnings, growth drivers and pipeline momentum lift outlooks.…
Which Pharma Giant Offers Better Growth: AstraZeneca or AbbVie?
AZN and ABBV both boast strong drug pipelines and growth outlooks, but differences in valuation, dividends and LOE risks set…
Mineralys: Hold As Hypertension OSA Data Barely Delivers And AstraZeneca On The Move
…
IRW-News: ACCESS Newswire: AstraZeneca und OMP demonstrieren auf dem Gartner Supply Chain Symposium/Xpo(TM) 2026 Planung im Tempo des Wandels
IRW-PRESS: ACCESS Newswire: AstraZeneca und OMP demonstrieren auf dem Gartner Supply Chain Symposium/Xpo(TM) 2026 Planung im Tempo des WandelsWie eine…
Total Voting Rights and Admission of Shares
1 May 2026Total Voting Rights and Notification of Admission of Further Securities to Trading (PRM 1.6.4R)Total Voting RightsThe following notification…
AstraZeneca stock falls after FDA panel votes against new cancer drug
The advisory panel wasnt convinced that a clinical trial proved that early switching to camizestrant improved long-term survival rates.…